{"id":1106402,"title":"DSEN Abstract: Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T10:54:59.120000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52735.html?wbdisable=true","snippet":"DSEN Abstract Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada In 2019, some batches of ranitidine, a readily available histamine H-2 receptor antagonist that counteracts stomach acid, contained an impurity called N-nitrosodimethylamine…","rawSnapshotUrl":"/api/snapshots/raw/1106402","browseUrl":"https://replay.healtharchive.ca/job-8/20260227105459/https://cihr-irsc.gc.ca/e/52735.html?wbdisable=true#ha_snapshot=1106402","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}